VOLITIONRX LTD — Director's Dealing 2022

Apr 13, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-04-11-05:00

Reporting Person: TERRELL JASON BRADLEY MD (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-04-11-05:00	Common Stock	S	10000	$2.75	Disposed	27249	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	955	Indirect